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Abstract
Background: In order to facilitate the completeness and transparency of reporting on randomized controlled trials
undertaken using acupuncture interventions, a consensus group of international experts developed the Standards
for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) in 2002. This reporting guideline was updated
in 2010, and was applicable to a broader range of acupuncture research, including uncontrolled trials and case reports.
Subsequent evaluations have noted limitations on the impact of STRICTA in the reporting quality of acupuncture trials,
and the description of acupuncture details remains poor. Thus improvement in the efficacy of the STRICTA guidelines is
called for.
Discussion: We explored the STRICTA guidelines from four aspects, including the development procedure, validity
assessment, endorsement and adherence, and citation situation. Based upon these findings, we provided five potential
suggestions for further development of STRICTA.
Summary: STRICTA are valid reporting guidelines based on robust methodology and scientific content. However
specific implementation strategies including: updating the STRICTA checklist; improving the STRICTA reporting
efficiency; consistency with implementing the “Instructions for authors” for journals; establishing global STRICTA
research centers; and expanding the STRICTA website, are needed. Such strategies will improve their utilization
and impact positively on the quality of reporting on acupuncture research outcomes.
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Background
In 2001, an international group of acupuncture researchers
developed a recommendation entitled Standards for
Reporting Interventions in Controlled Trials of Acupuncture
(STRICTA) to address reporting issues of controlled trials
using acupuncture. It was expected that the use of
STRICTA would bring better quality reporting on acupunc-
ture interventions, help the interpretation and analysis, and
enable research replications.
Seven years after the initial introduction of STRICTA,
Prady et al explored the possible impact of STRICTA on
the reporting of acupuncture interventions. They con-
ducted systematic reviews with before-and-after approaches
to examine whether more STRICTA items were fulfilled in
randomized controlled trials (RCTs) over time. Their
findings showed that the publication of STRICTA did
not have the anticipated impact in that the description
of acupuncture trials and the reporting quality
remained poor [1]. Four years later, Hammerschlag et
al developed a comprehensive reporting quality assess-
ment tool (Oregon CONSORT STRICTA Instrument)
to evaluate the quality of reporting of RCTs on the use
of acupuncture. It was found that although the
STRICTA-based reporting improved by 17 % over the
period from 1997 to 2007, there was a continual need
to enhance the quality of reporting details specific to
acupuncture intervention [2]. In the past three years,
there has been an increasing tendency to assess the
potential effects of STRICTA on the reporting of
acupuncture for various clinical diseases, including the
diabetic peripheral neuropathy, cancer pain, and neck
disorders. However, similar conclusions have been
drawn. It would appear that STRICTA have failed to
bring the reporting of acupuncture interventions to an
acceptable level, and specific implementations are
needed to improve the efficacy of STRICTA [3–5].
In order to investigate a potential way forward to
improve on the reporting, we considered the STRICTA
guidelines from four different aspects (development
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procedure, validity assessment, endorsement and adher-
ence, and citation situation), and have made recommenda-
tions for potential approaches for further development.
Discussion
Development of STRICTA
In July 2001, a consensus group of international experts
worked on the development of a standard for reporting
on RCTs undertaken using acupuncture interventions.
The experts comprised academic researchers and experi-
enced acupuncturists, as well as editors of five key Com-
plementary and Alternative Medicine (CAM) journals
(Acupuncture in Medicine, Clinical Acupuncture and
Oriental Medicine, Complementary Therapies in Medicine,
Journal of Alternative and Complementary Medicine, and
Medical Acupuncture). The STRICTA guidelines were sub-
sequently published in late 2001 and early 2002 [6–10].
Acting as an extension of the Consolidated Standards of
Reporting Trials (CONSORT) statement [11], STRICTA
were divided into six categories with 19 sub-items to ad-
dress the specific needs of adequately describing acupunc-
ture interventions: acupuncture rationale, needling details,
treatment regimen, co-interventions, practitioner back-
ground, and control interventions. It was anticipated by the
development team that the full reporting of these items
would enhance accurate analysis and interpretation, and
ease replication of acupuncture research. To broaden their
use internationally the standards were subsequently trans-
lated into Chinese, Japanese, and Korean.
As with any such standard, the STRICTA need timely,
ongoing review and updating. Seven years after the
original release of STRICTA, two reviews [1, 12] were
published. These assessed the utility and impact of the
STRICTA guidelines on the quality of reporting for acu-
puncture trials. Both reviews recommended STRICTA
be revised to reduce the ambiguity of items. The revision
process was initiated in 2008 and involved a collabor-
ation of the STRICTA Group, the CONSORT Group,
the Chinese Cochrane Centre, and a range of professionals
with specific expertise, including acupuncturists, physi-
cians, academic personnel, and journal editorial board
members [13].
Through a multi-staged procedure of expert consultation,
consensus workshops, draft editing, and finalization, the re-
vised STRICTA guidelines were agreed upon, and the final
document was co-published in 2010 by six medical journals
(Acupuncture in Medicine, Australian Journal of Acupunc-
ture and Chinese Medicine, Journal of Alternative and
Complementary Medicine, Journal of Evidence-Based Medi-
cine, Medical Acupuncture, and PLoS Medicine) [14–19].
As a standalone checklist STRICTA 2010 became an
official extension to CONSORT containing six categories
with 17 sub-items. In order to minimize misunderstanding
and ambiguity, specific explanations were added for each
sub-item, and examples of ‘good reporting’ were included.
The updated STRICTA were applicable to a broad range of
clinical research, including RCTs (same as STRICTA 2002),
uncontrolled studies, and case reports. Furthermore the
standards were also translated into a fourth language,
Russian.
Validity of STRICTA
Any reporting guidelines should meet minimum standards
for validity including a robust methodology and scientific-
ally validated content. A large number of reporting guide-
lines have been developed during the past decade [20];
however, the quality of these is not always clear: one
systematic review evaluated 81 reporting guidelines, and
noted problems with development, based upon question-
able methodologies [21]. The development approach has
not been independently analyzed for STRICTA, as a
reporting guideline. To address this issue, we used two
frameworks suggested by the Enhancing the Quality and
Transparency of Health Research (EQUATOR) network
(http://www.equator-network.org) [22]: 1) Guidance for
Developers of Health Research Reporting Guidelines
[21] which provides prospective reporting guideline de-
velopers with widely accepted methodologies during
the development procedure, and 2) the Template for
Intervention Description and Replication (TIDieR) [23],
which recommends the minimal essential items for
describing an intervention. It was hypothesized that
with the help of the two frameworks we could provide
a quantitative basis for assessment of the STRICTA
2010 based on the robustness of the guideline develop-
ment process as well as the content integrity.
The STRICTA guidelines 2010 [14] were used as the
primary assessment material; in addition, the reference
list and the official website of STRICTA (http://
www.stricta.info) [24] were scanned to identify further
articles and/or information concerning its develop-
ment process. As it was an initial evaluation, we did
not contact the authors to determine whether missing
items were completed and were available but not re-
ported. We converted the two frameworks [21, 23] into
two validity assessment checklists. Items were closely
aligned with the original recommendations, and the
answers could be simply given as “Yes” or “No”. Prior
to assessment, each topic on the checklists was inten-
sively discussed to achieve consensus on interpret-
ation; two reviewers (LL and PK) then independently
rated the validity of the STRICTA. The inter-rater
reliability was calculated using the kappa statistic;
disagreements were resolved by discussion, and an in-
dependent decision was obtained from a third author
(GDB) when disagreement persisted.
Four relevant papers [1, 12–14] plus the STRICTA
website were identified and served as primary source for
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assessment. Agreement of the reviewers for the two
checklists was regarded as excellent for independent re-
views, with a kappa index of 0.785 for the development
process and 0.873 for the content integrity. After discus-
sion the reviewers reached consensus giving a kappa
index of 1. Table 1 and Table 2 present the assessment
results. For the two checklists, the STRICTA guidelines
(2010) satisfied over half of the items (11/18 for the
guideline development process, and 8/12 for the content
integrity). While the STRICTA group publicized details
regarding the development procedures for the initial
steps, the post-meeting and the post-publication activ-
ities, details on the transparency of the pre-meeting
activities and the face-to-face consensus meeting were
mostly not disclosed. As for the content validity of the
STRICTA 2010, four missing items revealed room for
improvement, namely Item 6: delivery modes descrip-
tion; Item 10: intervention modifications explanation;
Item 11: planned intervention fidelity assessment; and
Item 12: actual results.
Endorsement and adherence to STRICTA
Currently nine international medical journals endorse
the STRICTA (2010), including seven CAM specialties
and two general medicine journals. A full list of partici-
pating journals and their STRICTA publications are
available at http://www.stricta.info/journals.html [25].
In order to investigate adherence to STRICTA, we
scanned “Instructions to Authors” on the websites of
those journals that endorse the standard, and extracted
relevant information. In addition, in order to examine
the awareness of reporting guidelines of those journals,
where there was mention of other research reporting
guidelines and/or the EQUATOR network this was also
extracted. Of the nine journals, six mentioned STRICTA
in the online version of “Instructions to Authors” (Table 3).
However, the majority of journals (n = 5) did not make it
an explicit requirement to use STRICTA for potential
manuscripts. Only one journal, Medical Acupuncture,
enforced strict use of the checklist as a compulsory re-
quirement for article submission. It elaborated on the
need to adhere to STRICTA throughout the process of
manuscript preparation, including appropriate sequencing
of the STRICTA items to follow, and the six STRICTA
categories required in the methodology section. In regard
to referencing, the majority of journals (n = 5) referred to
the current STRICTA website, but one referred to a URL
currently inaccessible. Two journals included the full
STRICTA (2010) Guidelines (one of which was via the
STRICTA website). The EQUATOR network was refer-
enced by only two of the endorsing journals, and other
relevant reporting guidelines (e.g. CONSORT, PRISMA,
and STARD) were also recommended for use by six
journals.
Table 1 Validity assessment of the STRICTA 2010 on reporting guidelines development process※
Step Item No. Item Satisfaction of STRICTA 2010
Initial steps 1 Identify the need for a guideline Yes
2 Review the literature Yes
3 Obtain funding for the guideline initiative Yes
Pre-meeting activities 4 Identify participants Yes
5 Conduct a Delphi exercise No
6 Generate a list of items for consideration at the face-to-face meeting No
7 Prepare for the face-to-face meeting No
Face-to-face consensus
meeting itself
8 Present and discuss results of pre-meeting activities and relevant
evidence
No
Post-meeting activities 9 Develop the guidance statement Yes
10 Develop an explanatory document (E&E) Yes
11 Develop a publication strategy Yes
Post-publication activities 12 Seek and deal with feedback and criticism Yes
13 Encourage guideline endorsement Yes
14 Support adherence to the guideline No
15 Evaluate the impact of the reporting guidance No
16 Develop Web site Yes
17 Translate guideline Yes
18 Update guideline No
※Structured according to the EQUATOR Guidance for Developers of Health Research Reporting Guidelines [21]
E&E: explanation and elaboration
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The availability of reporting guidelines by itself is not
sufficient to drive improvements in the completeness of
reporting: journal practices clearly have a major role to
play [26, 27]. However, the extent to which the journals
endorse and adhere to the reporting guidelines seems to
vary widely [28]. The most well-known reporting guide-
line, CONSORT, has been adopted by 585 biomedical
journals, and empirical evidence supports the view that
the implementation of CONSORT has been associated
with improved reporting of randomized trials [1, 29]. This
has been achieved over an extensive period of nearly two
decades (CONSORT was initially introduced in 1996).
Given such timescales in the uptake of reporting guide-
lines by journals, sufficient time should be allowed prior
to assessing the level of awareness of any new guideline
such as STRICTA [30]. There might be intrinsic chal-
lenges for STRICTA to obtain a degree of support
comparable to CONSORT, as it is a ‘specialty-specific’
reporting guideline not applicable for all journals; this
notwithstanding, it follows that more strict enforce-
ment of STRICTA within the endorsed journals is more
likely to yield the benefits for which it was intended.
Table 2 Validity assessment of the STRICTA 2010 on content integrity*
Item No. Item Satisfaction of STRICTA 2010
1 Brief name Yes
Provide the name or a phrase that describes the intervention
2 Why Yes
Describe any rationale, theory, or goal of the elements essential to the intervention
3 What (materials) Yes
Describe any physical or informational materials used in the intervention, including those
provided to participants or used in intervention delivery or in training of intervention
providers. Provide information on where the materials can be accessed (such as online
appendix, URL)
4 What (procedures) Yes
Describe each of the procedures, activities, and/or processes used in the intervention, including
any enabling or support activities
5 Who provided Yes
For each category of intervention provider (e.g. psychologist, nursing assistant), describe their
expertise, background and any specific training given
6 How No
Describe the modes of delivery (e.g. face-to-face or by some other mechanism, such as internet
or telephone) of the intervention and whether it was provided individually or in a group
7 Where Yes
Describe the type(s) of location(s) where the intervention occurred, including any necessary
infrastructure or relevant features
8 When and how much Yes
Describe the number of times the intervention was delivered and over what period of time including
the number of sessions, their schedule, and their duration, intensity or dose
9 Tailoring Yes
If the intervention was planned to be personalised, titrated or adapted, then describe what, why, when,
and how
10∮ Modifications No
If the intervention was modified during the course of the study, describe the changes (what, why,
when, and how)
11 How well (planned) No
If intervention adherence or fidelity was assessed, describe how and by whom, and if any strategies
were used to maintain or improve fidelity, describe them
12∮ How well (actual) No
If intervention adherence or fidelity was assessed, describe the extent to which the intervention was
delivered as planned
*Structured according to the Template for Intervention Description and Replication (TIDieR) [23]
∮Not applicable to a protocol
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Citation of STRICTA
As fourteen years have elapsed since STRICTA were first
published, we think it is timely to examine the utilization
and potential impacts of STRICTA.
Although it is possible to measure the impact of
STRICTA in numerous ways, perhaps the most logical
(if novel) approach is examination of citations for STRICTA.
Furthermore a broad search of the literature has shown that
previous reviews of STRICTA have been limited to English-
language papers (and papers published in English) [1]. We
therefore decided to conduct a comprehensive evaluation
of the application of STRICTA in relevant articles in
three publication languages - English, Chinese, and Japanese.
The latter two are considered representative of the main
acupuncture research in Asian countries.
In our approach we used Cited Reference Search and/or
Citation Tracker (slight differences in different databases)
for two English databases (Web of Science and Scopus),
one Chinese database (China National Knowledge Infra-
structure) and one Japanese database (Japan Science and
Technology Information Aggregator, Electronic) to explore
citations for STRICTA 2002 and STRICTA 2010 from
2002 up to January 2015. For the literature in English,
full titles of publications were used as search terms.
Due to potential limitations on the dissemination of the
English STRICTA in non-English speaking countries,
the key word and/or the topic of “STRICTA” were used
as additional search terms in both Chinese and Japanese
databases. Two standardized spreadsheets were used to
record the basic characteristics of articles regarding the
publication year, study type, and the journal type
(general medical non-CAM journals, specialty medical
non-CAM journals, CAM journals with STRICTA en-
dorsement, and CAM journals without STRICTA en-
dorsement) [1]. We calculated the annual STRICTA
citation counts, including those relating exclusively to
RCTs and related studies (e.g. protocols) for which
STRICTA was initially designed. We then set up line
plots to investigate the possible changes in citations
over time. Linear regression (the Spearman’s rank cor-
relation) was used to identify the potential predictors of
citation counts, i.e. the language of publication, and the
year of publication.
Our search strategy resulted in the identification of
519 articles that cited STRICTA 2002 and 351 that cited
STRICTA 2010, and a further 47 articles in Chinese and
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11 in Japanese that mentioned STRICTA as either a key
word or topic. After excluding duplicates and those out-
side of the study limitations, a total of 536 papers were
eligible for inclusion. The main characteristics of the
articles are displayed in (Additional file 1: Table S1 and
Additional file 2: Table S2).
Overall citation counts increased over time. For the
STRICTA guidelines 2002, the two English databases
demonstrated growing citation numbers until the revised
STRICTA were published in 2010: it grew steadily from
two citations in 2002 to 40 citations in 2008, but plat-
eaued over the next two years (Fig. 1). In the context of
citations in RCTs, this similarly increased with some
oscillation from 2005 (three years after the initial intro-
duction); however, the counts were low (maximum of 11
citations in 2009) (Fig. 2). For the STRICTA guidelines
2010, continuing citation was found for both RCTs and
papers of other study types published in English (Figs. 3
and 4). By contrast, in the Chinese literature there were
fewer citations. Although there were small increases
(with some small variation), few authors referred to the
STRICTA guidelines in their publications: until the
end of 2014, the STRICTA 2002 was cited in total only
18 times and the STRICTA 2010 21 times; only seven
such RCTs have cited STRICTA over the past 14 years.
For citation in Japanese articles, STRICTA 2002 and
STRICTA 2010 were barely cited: seven articles cited the
STRICTA guidelines 2002 (published in the years 2002,
2005, 2008, 2010, 2013 and 2014, respectively), and only
one RCT article (2012) cited the revised STRICTA 2010.
Results of linear regression suggest that the date of pub-
lication was a significant predictor of increasing citation
counts for STRICTA guidelines 2010 in English litera-
ture (r = 0.900). With regard to journal of publication,
authors citing STRICTA 2002 preferred publishing the
articles in non-CAM specialty medical journals in the
English language, whilst those published in Chinese and
Japanese languages were in the CAM journals without
STRICTA endorsement (Fig. 5). In contrast, for STRICTA
2010, the most frequently cited were those published in
the CAM journals without STRICTA endorsement for
both English and Chinese languages (Fig. 6).
Implications for STRICTA
Since the first systematic review which examined the
impact of STRICTA on the reporting quality of acu-
puncture trials [1], subsequent evaluations have drawn
similar conclusions: it appears that STRICTA (2002 and
2010) has not improved the quality of reporting to the
degree anticipated, thus descriptions of the acupuncture
specific aspects of publications remain suboptimal [3–5].
Although a small increase (17 %) in reporting quality
was revealed by another review using a combined
CONSORT and STRICTA assessment instrument [2],
the reporting of practitioner background (e.g. training,
experience and expertise) is extremely poor, and there
continues to be a need for improvement in reporting on
the details of acupuncture trials [1, 2]. Besides potential
lack of awareness of the guidelines based on the limited







































Fig. 1 Citation of STRICTA 2002 in all studies
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that dissemination of the STRICTA guidelines was a limit-
ing factor in itself, though we acknowledge the means of
dissemination are clearly outlined on the web site.
In regard to potential for improvements with respect
to the dissemination and use of STRICTA (2010) the
following concepts could be considered. Firstly, it may
be beneficial to update the STRICTA checklist. As an of-
ficial extension of the CONSORT statement 2010 (item
5), the content integrity of the STRICTA guidelines may
be improved by embedding all the items suggested by
the TIDieR guidelines (which specify a minimum set of
items to describe an intervention) in the checklist. For
the STRICTA to remain credible it may be helpful to
collaborate with the TIDieR group, and to refer to the
other relevant reporting guidelines in the EQUATOR net-
work. The revision process might also benefit from solici-
tation of a wider range of expert opinions. It is argued
by Chinese scholars that several Traditional Chinese
Medicine characteristics of acupuncture (e.g. syndrome
differentiations, treatment opportunities, and disease
stages) have not been clearly articulated in STRICTA
[31]. Furthermore, it is also suggested that items con-
cerning the standards and precision of acupoint locali-
zations, the angle and direction of needle insertion, and
the acupuncture experiences of participants are in-
cluded in any future revision of STRICTA [31–33]. Fur-


































* The updated STRICTA available 
*

















































Fig. 4 Citation of STRICTA 2010 in RCTs
Liu et al. BMC Complementary and Alternative Medicine  (2015) 15:190 Page 7 of 11
be standardized with the current format and any modi-
fications or additions clearly highlighted.
A second strategy may be to improve the efficiency of
reporting by using a flowchart. As print journals have
limitations on manuscript length, full reporting of all
intervention details within one primary paper is almost
impossible, especially when the study protocols or
relevant papers have not been previously published. Al-
though hosting the specific components in relevant
websites may seem to be a rational solution, there are
inherent risks such as resourcing, and responsibility for
maintaining the website. Such problems were revealed in
a recent review which evaluated the description of non-
pharmacological interventions in randomized trials [34]. A
more fruitful approach might be to provide a graphical
representation instead of text descriptions of the details of
the interventions. This might be based on a flowchart with
squares and circles which represent the objects and activ-
ities of each treatment arms in specific columns; below
the flowchart, a legend could provide brief instructions of
each components, including forms, contents, functions,
and details of the intervention providers [35]. Such an
approach may clarify the majority of components (except
for the rationale of interventions) required by the
STRICTA checklist. In addition, it may have advantages
and encourage the use of guidelines more rigorously
including: providing a better description of the interven-
tions, decreasing manuscript word count, promoting an
easier understanding of the trial structures, and helping
with the design and conduct of acupuncture research at
the early stage [36].
Thirdly, there is potential for journals that endorse
STRICTA to be more consistent with their requirements
for authors to adhere to the Guidelines. The benefits of
reporting in accordance with the guidelines, and in publi-
cations that use the guidelines was reinforced by Hopewell
et al [37] in their review of the CONSORT statement.
Likewise for STRICTA, we advocate for more consistent
enforcement of adherence to the guidelines. There con-
tinues to be a need for complete descriptions in clinical
trials of acupuncture. Thus it may be advantageous for the
STRICTA group to develop an official statement with a
clear message relating to adherence requirements. One
possible way forward would be to request authors to
Fig. 5 Publication location of articles citing STRICTA 2002
Fig. 6 Publication location of articles citing STRICTA 2010
Liu et al. BMC Complementary and Alternative Medicine  (2015) 15:190 Page 8 of 11
comply with reporting on specific details and submit a
completed STRICTA checklist as a requirement for con-
sideration for publication [37, 38]. This may be assisted in
the future by using web-based technologies that allow au-
tomated text identification for essential elements [39]. We
suggest the statement be included in the published
“Instructions to Authors” for the relevant journal. In
addition, an appropriate reference to the STRICTA
guidelines and an accessible URL of the STRICTA
web site, as author support resources would also be
expected to be provided by the journal. As it is argued by
some that reviewers and editors unfamiliar with STRICTA
may be responsible for the missing details relating to
acupuncture in the final publications [12], health related
journals would need to ensure their editorial staff enforce
adherence to STRICTA, and incorporate the checklist into
the peer-review and editorial processes. In addition, jour-
nals may consider providing editorials to encourage use,
the positive impacts of which have been demonstrated by
the greater degree of CONSORT implementation [38, 40].
Although STRICTA is designed mainly for clinical tri-
als, its application may also be usefully applied to sys-
tematic reviews. The reporting quality of RCTs has been
shown to be better than that of systematic reviews [41],
and for Cochrane reviews of acupuncture, the reporting
of treatment details has been noted to be inadequate
[30]. As few reviews recommend appropriate treatment
regimen(s) to be used in routine practice, practitioners
in such cases are unable to use the related evidence to
inform their treatments [41]. Thus, it may be beneficial
for journals to widen the use of STRICTA to acupunc-
ture reviews, which would improve the applicability and
utilization of review results in future research and clin-
ical practice.
Fourthly, as there is evidence of a lack of consistency
among journals not published in the English language, it
may be beneficial to implement a strategy where the Guide-
lines are more strictly endorsed in non-English speaking
countries. Our findings showed growing levels of uptakes
of STRICTA in the English literature, but the citations of
STRICTA in Asian articles, such as Chinese and Japanese,
appeared inconsistent and remain low. It seems that other
strategies besides the STRICTA translations are worthy of
consideration. As there is a large amount of acupuncture
research undertaken in non-English-speaking countries, for
example in China, Japan, Korea, and Germany, it may be
feasible to develop a global network of STRICTA research
centers. Possible missions of these centers would be to
organize regular education and training workshops or
seminars (including webinars) which concentrate on the
efficient use of the STRICTA guidelines and good research
reporting practices, seek users’ feedback, handle criticism
from all stakeholders, and maximize endorsements and
adherence to STRICTA in local journals.
Fifthly, consideration could be given to updating and
expanding the STRICTA website. Our findings show
that details on key elements of the development proced-
ure of the STRICTA guidelines, such as the pre-meeting
activities and the face-to-face consensus meeting, is not
publicly available (or is hard to locate). This finding
concurred with the previous systematic review by Moher
et al in which the authors noted the problems of non-
transparent processes for the development of, and
reporting on, guidelines [42]. It may be possible to
provide the update data of STRICTA on the web site,
and append this address in articles on the Guidelines.
Beyond this, related papers that have evaluated the
reporting quality of the acupuncture studies could be
included on the web site, to inform the impact of
STRICTA, and to help maintain it. It is expected that
such evaluations could be undertaken collaboratively by
different research parties including authors, editors, pub-
lishers and funders. This may reduce the risk of bias in
self-evaluations, and also provide a better opportunity
for broader support [43]. It may also be useful to include
a “News” section concerning any new issues related to
the guidelines such as plans for updates, and perhaps
the STRICTA centers, if possible.
Finally, we recommend providing the linkage to the
EQUATOR network (http://www.equator-network.org)
[22], a repository for good reporting guidelines for
health research, on the STRICTA web site, to im-
prove the general standards of reporting of research
within the field of acupuncture.
Summary
A complete description of complex interventions is chal-
lenging [23]; the process of treatment such as specific
regimens and description of the necessary materials, are
often missing from such descriptions [41]. Problems
with this inadequate reporting have led to the creation
of several reporting guidelines, including STRICTA and
those in other areas such as homeopathy, yoga, and
moxibustion [44–46]. Although it is encouraging to note
that the development of these reporting guidelines may
be one valuable step towards the enhancement of report-
ing quality and research reliability, it is only a first step.
Given the low utilization, and consequently the limited
impact, of these guidelines, specific implementation
strategies are necessary to remedy this situation.
We believe that the quality of reporting of the inter-
ventions in clinical trials of acupuncture will only be im-
proved by wide dissemination and strict adherence to
the STRICTA guidelines. Beyond the current implemen-
tation measures such as co-publications and translations
into other languages, more effort is needed to disseminate
and promote the more widespread use of STRICTA. All
stakeholders (i.e. researchers, journal publishers, funding
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organizations, policy regulators) should take a shared
responsibility to collaborate to implement STRICTA to a
greater extent. This will, in turn, ensure the quality of re-
ports of acupuncture studies is improved, thus assisting
the potential for research results to be efficiently translated
into clinical practice. As there is a lack of sufficient fund-
ing for developing reporting guidelines [43], we particu-
larly appeal to the health research funding organizations
to emphasize the importance of STRICTA, and ensure
dedicated funding to support its revision and maintenance
on a routine basis in future. Such support is believed to
influence reporting quality and, therefore, the subsequent
impact, of future acupuncture research.
It may be argued by some that if the reporting guide-
lines themselves are deficient, this would undermine
their impact on improvement in scientific quality and
thus the benefits to clinical practice. However, it may
also be argued that improvements in the reporting
guidelines are based on their wide utilization and expos-
ure to critical appraisal. Continual improvement in the
quality of reporting related to particular treatment inter-
ventions will also benefit clinical practice and drive re-
search further forward.
As yet there are no formal tools to assess the validity
of the reporting guidelines; the Guidance for Developers
of Health Research Reporting Guidelines [21] and the
TIDieR [23] are designed to inform the development of
reporting guidelines. We used the original format of the
TIDieR, and kept the 18 primary items of the Guidance
for Developers of Health Research Reporting Guidelines.
Our two validity checklists are helpful but do have limi-
tations, as some items are optional and there is no
weighting criteria of individual items. Hence, in order to
reduce bias, we call for more researchers to participate
in the evaluation, provide critical appraisements, and
help with the optimization of the STRICTA guidelines.
Additional files
Additional file 1: Table S1. Characteristics of articles cited STRICTA
2002. The table presents the characteristics of the articles that cited the
STRICTA guidelines 2002, including the title, author(s), publication year
and journal, study type, and journal type, of the articles.
Additional file 2: Table S2. Characteristics of articles cited STRICTA
2010. The table presents the characteristics of the articles that cited the
STRICTA guidelines 2010, including the title, author(s), publication year
and journal, study type, and journal type, of the articles.
Abbreviations
STRICTA: Standards for Reporting Interventions in Controlled Trials of
Acupuncture; RCTs: Randomized controlled trials; CAM: Complementary and
Alternative Medicine; CONSORT: Consolidated Standards of Reporting Trials;
EQUATOR: Enhancing the Quality and Transparency of Health Research;
TIDieR: Template for Intervention Description and Replication.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LL contributed to conception and design, literature search and selection,
data extraction, validity assessment, data analysis and interpretation, drafting
and revision. MS and SMcD contributed to design and revision. PK
contributed to literature search and selection, data extraction and validity
assessment. GDB contributed to study supervision, conception and design,
and revision. All authors read and approved the final manuscript.
Acknowledgments
The authors thank Mrs. Trish Leishman (Medical Librarian, University of
Otago) for suggestions of literature search; Mr. Jundong Wang for Chinese
literature identification and data extraction; Mr. Masashi Aoyagi for Japanese
literature identification and data extraction. Lizhou Liu is supported by a
University of Otago doctoral research scholarship.
Author details
1Centre for Health, Activity and Rehabilitation Research, School of
Physiotherapy, University of Otago, PO Box 56, 325 Great King Street,
Dunedin 9054, New Zealand. 2Centre for Health and Rehabilitation
Technologies, Institute of Nursing and Health Research, School of Health
Sciences, University of Ulster, Shore Road Newtownabbey, Co Antrim BT37
0QB, UK.
Received: 27 January 2015 Accepted: 9 June 2015
References
1. Prady SL, Richmond SJ, Morton VM, MacPherson H. A systematic evaluation
of the impact of STRICTA and CONSORT recommendations on quality of
reporting for acupuncture trials. PLoS ONE. 2008;3(2):e1577.
2. Hammerschlag R, Milley R, Colbert A, Weih J, Yohalem-Ilsley B, Mist S, Aickin M:
Randomized Controlled Trials of Acupuncture (1997-2007): An Assessment of
Reporting Quality with a CONSORT- and STRICTA-Based Instrument. Evid Based
Complement Alternat Med 2011, 2011. doi: 10.1155/2011/183910
3. Chu TWT, Guo YQ, Brian T, Chen LY. Reporting quality of english randomized
controlled trials on acupuncture for neck disorders by the CONSORT statement
and STRICTA. Chinese Journal of Evidence-Based Medicine. 2014;14(1):115–9.
4. Lu L, Liao M, Zeng J, He J. Quality of reporting and its correlates among
randomized controlled trials on acupuncture for cancer pain: Application of
the CONSORT 2010 Statement and STRICTA. Expert Rev Anticancer Ther.
2013;13(4):489–98.
5. Chen B, Zhao X, Guo Y, Chen ZL, Bai Y, Wang ZX, et al. Assessing the
Quality of Reports about Randomized Controlled Trials of Acupuncture
Treatment on Diabetic Peripheral Neuropathy. PLoS ONE. 2012;7(7):e38461.
6. MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R.
Standards for reporting interventions in controlled trials of acupuncture: the
STRICTA recommendations. Complement Ther Med. 2001;9(4):246–9.
7. MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R.
Standards for reporting interventions in controlled trials of acupuncture: The
STRICTA recommendations. STandards for Reporting Interventions in
Controlled Trails of Acupuncture. Acupunct Med. 2002;20(1):22–5.
8. MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R.
Standards for reporting interventions in controlled trials of acupuncture:
the STRICTA recommendations. Clinical Acupuncture and Oriental Medicine.
2002;3(1):6–9.
9. MacPherson H, White A, Cummings M, Jobst KA, Rose K, Niemtzow RC.
Standards for Reporting Interventions in Controlled Trials of Acupuncture:
the STRICTA recommendations. J Altern Complement Med. 2002;8(1):85–9.
10. MacPherson H, White A, Cummings M, Jobst KA, Rose K, Niemtzow RC.
Standards for Reporting Interventions in Controlled Trials of Acupuncture:
the STRICTA recommendations. Medical Acupuncture. 2002;13:9–11.
11. Moher D, Schulz K, Altman D. The CONSORT statement: revised
recommendations for improving the quality of reports of parallel group
randomized trials. BMC Med Res Methodol. 2001;1(1):2.
12. Prady SL, MacPherson H. Assessing the utility of the Standards for Reporting
Trials of Acupuncture (STRICTA): A survey of authors. J Altern Complement
Med. 2007;13(9):939–43.
13. MacPherson H, Altman DG. Improving the quality of reporting acupuncture
interventions: describing the collaboration between STRICTA, CONSORT and
the Chinese Cochrane Centre. Journal of Evidence-Based Medicine.
2009;2(1):57–60.
Liu et al. BMC Complementary and Alternative Medicine  (2015) 15:190 Page 10 of 11
14. MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, et al.
Revised standards for reporting interventions in clinical trials of acupuncture
(STRICTA): Extending the consort statement. Acupuncture in Medicine.
2010;28(2):83–93.
15. MacPherson H, Altman DG, Hammerschlag R, Li YP, Wu TX, White A, et al.
Revised STandards for Reporting Interventions in Clinical Trials of
Acupuncture (STRICTA): Extending the CONSORT Statement. J Altern
Complement Med. 2010;16(10):ST1–ST14.
16. MacPherson H, Altman DG, Hammerschlag R, Li YP, Wu TX, White A, et al.
Revised STandards for Reporting Interventions in Clinical Trials of
Acupuncture (STRICTA): Extending the CONSORT Statement. PLoS Med.
2010;7(6):e1000261.
17. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White
A, et al. Revised Standards for reporting interventions in clinical trials of
acupuncture (STRICTA): Extending the CONSORT Statement. Medical
Acupuncture. 2010;22(3):167–80.
18. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White
A, et al. Revised STandards for Reporting Interventions in Clinical Trials of
Acupuncture (STRICTA): Extending the CONSORT statement. Journal of
Evidence-Based Medicine. 2010;3(3):140–55.
19. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White
A, et al. Revised Standards for reporting interventions in clinical trials of
acupuncture (STRICTA): Extending the CONSORT Statement. Australian
Journal of Acupuncture and Chinese Medicine. 2010;5(2):8–22.
20. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting
guidelines for health research. Eur J Clin Invest. 2010;40(1):35–53.
21. Moher D, Schulz KF, Simera I, Altman DG. Guidance for Developers of
Health Research Reporting Guidelines. PLoS Med. 2010;7(2):e1000217.
22. EQUATOR Network [http://www.equator-network.org/]
23. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al.
Better reporting of interventions: Template for intervention description and
replication (TIDieR) checklist and guide. BMJ (Online). 2014;348:g1687.
24. STandards for Reporting Interventions in Controlled Trials of Acupuncture
[http://www.stricta.info/]
25. STRICTA Participating Journals [http://www.stricta.info/journals.html]
26. Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG. Transparent and
accurate reporting increases reliability, utility, and impact of your research:
reporting guidelines and the EQUATOR Network. BMC Med. 2010;8:24.
27. Altman DG, Simera I, Hoey J, Moher D, Schulz K. EQUATOR: reporting
guidelines for health research. Lancet. 2008;371(9619):1149–50.
28. McLeroy KR, Northridge ME, Balcazar H, Greenberg MR, Landers SJ.
Reporting guidelines and the American Journal of Public Health's adoption
of Preferred Reporting Items for Systematic reviews and Meta-Analyses. Am
J Public Health. 2012;102(5):780–4.
29. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the
CONSORT checklist improve the quality of reports of randomised controlled
trials? A systematic review. Med J Aust. 2006;185(5):263–7.
30. Kim KH, Kang JW, Lee MS, Lee J-D. Assessment of the quality of reporting
for treatment components in Cochrane reviews of acupuncture. BMJ Open.
2014;4(1):e004136.
31. Liu T, Zhou SY, Chen DS, Qin HZ, Su ZW, Li Y. Quality improvement on
acupuncture intervention report: application and perfection of STRICTA.
Chinese Acupuncture and Moxibustion. 2013;33(9):856–9.
32. Dorsher PT. The 2001 STRICTA recommendations for reporting acupuncture
research: a review with implications for improving controlled clinical trial
design. J Altern Complement Med. 2009;15(2):147–51.
33. Bian ZX, Chang YH. Revised STRICTA as an extension of the CONSORT
statement: more items should be involved in the checklist. J Altern
Complement Med. 2011;17(2):97–8.
34. Hoffmann TC, Erueti C, Glasziou PP. Poor description of non-pharmacological
interventions: analysis of consecutive sample of randomised trials. BMJ.
2013;347:f3755.
35. Perera R, Heneghan C, Yudkin P. Graphical method for depicting
randomised trials of complex interventions. BMJ. 2007;334(7585):127–9.
36. Narahari SR, Ryan TJ, Aggithaya MG, Bose KS, Prasanna KS. Evidence-based
approaches for the Ayurvedic traditional herbal formulations: toward an
Ayurvedic CONSORT model. J Altern Complement Med. 2008;14(6):769–76.
37. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT
Statement by high impact factor medical journals: a survey of journal
editors and journal 'Instructions to Authors'. Trials. 2008;9:20.
38. Mills E, Wu P, Gagnier J, Heels-Ansdell D, Montori VM. An analysis of general
medical and specialist journals that endorse CONSORT found that reporting
was not enforced consistently. J Clin Epidemiol. 2005;58(7):662–7.
39. Shamseer L, Galipeau J, Turner L, Moher D. Improving the reporting and
usability of research studies. Can J Anaesth. 2013;60(4):337–9.
40. Mills EJ, Wu P, Gagnier J, Devereaux PJ. The quality of randomized trial
reporting in leading medical journals since the revised CONSORT statement.
Contemp Clin Trials. 2005;26(4):480–7.
41. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from
descriptions of treatment in trials and reviews? BMJ. 2008;336(7659):1472–4.
42. Moher D, Weeks L, Ocampo M, Seely D, Sampson M, Altman DG, et al.
Describing reporting guidelines for health research: a systematic review.
J Clin Epidemiol. 2011;64(7):718–42.
43. Simera I, Altman DG, Moher D, Schulz KF, Hoey J. Guidelines for reporting
health research: the EQUATOR network's survey of guideline authors. PLoS
Med. 2008;5(6):e139.
44. Dean ME, Coulter MK, Fisher P, Jobst KA, Walach H. Reporting data on
homeopathic treatments (RedHot): a supplement to CONSORT. J Altern
Complement Med. 2007;13(1):19–23.
45. Sherman KJ. Guidelines for developing yoga interventions for randomized
trials. Evid Based Complement Alternat Med. 2012;2012:143271.
46. Cheng CW, Fu SF, Zhou QH, Wu TX, Shang HC, Tang XD, et al. Extending
the CONSORT Statement to moxibustion. J Integr Med. 2013;11(1):54–63.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liu et al. BMC Complementary and Alternative Medicine  (2015) 15:190 Page 11 of 11
